The BREASTrial Stage III: Acellular Dermal Matrix Breast Reconstruction Outcomes from 3 Months to 2 Years Postoperatively

SD Mendenhall, WD Moss, EM Graham… - Plastic and …, 2023 - journals.lww.com
Background: The Breast Reconstruction Evaluation of Acellular Dermal Matrix as a Sling
Trial (BREASTrial) is a blinded, randomized trial comparing the outcomes of tissue expander …
相关文章

The BREASTrial Stage III: Acellular Dermal Matrix Breast Reconstruction Outcomes from Three Months to Two Years Postoperative.

SD Mendenhall, W Moss, EM Graham… - Plastic and …, 2022 - europepmc.org
Background The Breast Reconstruction Evaluation of Acellular Dermal Matrix (ADM) as a
Sling Trial is a blinded, randomized trial comparing the outcomes of tissue expander breast …

The BREASTrial Stage III: Acellular Dermal Matrix Breast Reconstruction Outcomes from 3 Months to 2 Years Postoperatively

SD Mendenhall, WD Moss, EM Graham, G Carter… - 2023 - pubmed.ncbi.nlm.nih.gov
Background The Breast Reconstruction Evaluation of Acellular Dermal Matrix as a Sling
Trial (BREASTrial) is a blinded, randomized trial comparing the outcomes of tissue expander …
[PDF] ivysociety.org

[PDF][PDF] The BREASTrial Stage III: Acellular Dermal Matrix Breast Reconstruction Outcomes from 3 Months to 2 Years Postoperatively

SD Mendenhall, WD Moss, G Carter… - Plastic and …, 2023 - ivysociety.org
Background: The Breast Reconstruction Evaluation of Acellular Dermal Matrix as a Sling
Trial (BREASTrial) is a blinded, randomized trial comparing the outcomes of tissue expander …

The BREASTrial Stage III: Acellular Dermal Matrix Breast Reconstruction Outcomes from 3 Months to 2 Years Postoperatively

SD Mendenhall, WD Moss, EM Graham… - Plastic and …, 2022 - ingentaconnect.com
Background: The Breast Reconstruction Evaluation of Acellular Dermal Matrix as a Sling
Trial (BREASTrial) is a blinded, randomized trial comparing the outcomes of tissue expander …